Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

74
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
74
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

6.2K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
6.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

67
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
67

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A STING-mediated trialogue: co-ordinating the CD8+ T-cell assault in doxorubicin cardiomyopathy.

Cardiovascular research·2026
Same author

Function and Quality of Life 5 Years Following Pediatric Major Trauma: A Population-Based Cohort Study.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches·2026
Same author

GOLD 2026 COPD ABE assessment tool to identify individuals at high risk in a UK multicentre COPD cohort (ERICA).

BMJ open respiratory research·2026
Same author

Translating genome-wide association studies at multiple scales: Drug target prioritization, cellular architectures, and organ imaging.

Cell genomics·2026
Same author

Left atrial stiffness, exercise intolerance and injury biomarkers predict adverse outcomes in patients with heart failure with preserved ejection fraction.

NPJ cardiovascular health·2026
Same author

Author's Reply to: "Comment on: Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials Including 31,397 Subjects Worldwide".

American journal of cardiovascular drugs : drugs, devices, and other interventions·2026
Same journal

Aortic Valve Replacement in Women of Reproductive Age.

Journal of the American College of Cardiology·2026
Same journal

Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

Journal of the American College of Cardiology·2026
Same journal

Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Journal of the American College of Cardiology·2026
Same journal

Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

Journal of the American College of Cardiology·2026
Same journal

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same journal

The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

Journal of the American College of Cardiology·2026
See all related articles

Related Experiment Video

Updated: Oct 20, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K

Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction.

Xian Yu1, Stephen A Newland2, Tian X Zhao2

  • 1Department of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom; Department of Cardiology, Union Hospital, Tongji, Medical College, Huazhong University of Science and Technology, Wuhan, China.

Journal of the American College of Cardiology
|September 10, 2021
PubMed
Summary
This summary is machine-generated.

Innate lymphoid cells type 2 (ILC2s) promote heart healing after myocardial infarction (MI) in mice. Activating ILC2s with low-dose interleukin-2 (IL-2) may offer a new therapy for MI recovery.

Keywords:
cytokinesheart failureinnate lymphoid cellsinterleukin-2lymphocytesmyocardial infarction

More Related Videos

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.8K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

6.4K

Related Experiment Videos

Last Updated: Oct 20, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.8K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

6.4K

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Regenerative Medicine

Background:

  • Innate lymphoid cells type 2 (ILC2s) are crucial for tissue homeostasis and limit atherosclerosis.
  • ILC2s are present in the pericardium, but their role in post-myocardial infarction (MI) injury is not understood.

Purpose of the Study:

  • To investigate the role of ILC2s in a mouse model of MI.
  • To explore the therapeutic potential of activating ILC2s for cardiac repair after MI.

Main Methods:

  • Genetic deletion of ILC2s in mice subjected to MI.
  • Assessment of infarct size and cardiac function via histology and echocardiography.
  • Flow cytometry and RNA sequencing to characterize cardiac ILC2s.
  • Therapeutic activation of ILC2s using interleukin-2 (IL-2) in mice and patients with acute coronary syndromes (ACS).

Main Results:

  • ILC2 levels increased in pericardial adipose tissue post-MI; ILC2 ablation impaired cardiac recovery.
  • RNA sequencing identified the IL-2 axis as a key regulator of ILC2 function.
  • IL-2 treatment improved heart function recovery in mice post-MI.
  • Low-dose IL-2 activated circulating ILC2s and increased IL-5 levels in patients with ACS.

Conclusions:

  • ILC2s enhance cardiac healing and improve heart function recovery following MI in mice.
  • Targeting ILC2 activation with low-dose IL-2 represents a potential therapeutic strategy for promoting cardiac repair after MI.